This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juffermans, N. P.
Right arrow Articles by van der Poll, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juffermans, N. P.
Right arrow Articles by van der Poll, T.

 Previous Article  |  Next Article 

Infection and Immunity, January 2002, p. 147-152, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.147-152.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

CpG Oligodeoxynucleotides Enhance Host Defense during Murine Tuberculosis

Nicole P. Juffermans,1,2 Jaklien C. Leemans,1 Sandrine Florquin,3 Annelies Verbon,1,2 Arend H. Kolk,4 Peter Speelman,2 Sander J. H. van Deventer,1 and Tom van der Poll1,2*

Laboratory of Experimental Internal Medicine,1 Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine, and AIDS,2 Department of Pathology,3 Academic Medical Center, University of Amsterdam, and the Royal Tropical Institute, Amsterdam, The Netherlands4

Received 7 May 2001/ Returned for modification 16 July 2001/ Accepted 27 September 2001

Oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs activate immune cells to produce cytokines. CpG ODNs protect mice against infections with intracellular bacteria by the induction of a T helper 1 (Th1) response. To determine the effect of CpG ODNs in pulmonary tuberculosis, mice were treated with CpG ODNs or control ODNs at the time of intranasal infection. CpG ODNs reduced mycobacterial outgrowth for up to 5 weeks after Mycobacterium tuberculosis infection and were associated with a decrease in inflammation in lung tissue. CpG treatment was also associated with elevated levels of gamma interferon (IFN-{gamma}) and decreased levels of interleukin 4 in the lungs and an increased capacity of splenocytes to secrete Th1-type cytokines. CpG ODNs given 2 weeks after infection were still able to reduce mycobacterial outgrowth and to enhance a Th1 response 5 weeks postinfection. Administration of CpG ODNs to IFN-{gamma}-gene-deficient mice failed to reduce mycobacterial outgrowth. These data suggest that CpG ODNs improve host defense during pulmonary tuberculosis by an IFN-{gamma}-dependent mechanism.


* Corresponding author. Mailing address: Academic Medical Center, Room G2-130, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Phone: 31-20-5669111. Fax: 31-20-6977192. E-mail: T.vanderPoll{at}amc.uva.nl.

Editor: S. H. E. Kaufmann


Infection and Immunity, January 2002, p. 147-152, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.147-152.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bhan, U., Trujillo, G., Lyn-Kew, K., Newstead, M. W., Zeng, X., Hogaboam, C. M., Krieg, A. M., Standiford, T. J. (2008). Toll-Like Receptor 9 Regulates the Lung Macrophage Phenotype and Host Immunity in Murine Pneumonia Caused by Legionella pneumophila. Infect. Immun. 76: 2895-2904 [Abstract] [Full Text]  
  • Goulding, J., Snelgrove, R., Saldana, J., Didierlaurent, A., Cavanagh, M., Gwyer, E., Wales, J., Wissinger, E. L., Hussell, T. (2007). Respiratory Infections: Do We Ever Recover?. Proc Am Thorac Soc 4: 618-625 [Abstract] [Full Text]  
  • Bhan, U., Lukacs, N. W., Osterholzer, J. J., Newstead, M. W., Zeng, X., Moore, T. A., McMillan, T. R., Krieg, A. M., Akira, S., Standiford, T. J. (2007). TLR9 Is Required for Protective Innate Immunity in Gram-Negative Bacterial Pneumonia: Role of Dendritic Cells. J. Immunol. 179: 3937-3946 [Abstract] [Full Text]  
  • Krieg, A. M. (2007). Antiinfective Applications of Toll-like Receptor 9 Agonists. Proc Am Thorac Soc 4: 289-294 [Abstract] [Full Text]  
  • Chen, L., Arora, M., Yarlagadda, M., Oriss, T. B., Krishnamoorthy, N., Ray, A., Ray, P. (2006). Distinct Responses of Lung and Spleen Dendritic Cells to the TLR9 Agonist CpG Oligodeoxynucleotide. J. Immunol. 177: 2373-2383 [Abstract] [Full Text]  
  • Wang, Y., Abel, K., Lantz, K., Krieg, A. M., McChesney, M. B., Miller, C. J. (2005). The Toll-Like Receptor 7 (TLR7) Agonist, Imiquimod, and the TLR9 Agonist, CpG ODN, Induce Antiviral Cytokines and Chemokines but Do Not Prevent Vaginal Transmission of Simian Immunodeficiency Virus When Applied Intravaginally to Rhesus Macaques. J. Virol. 79: 14355-14370 [Abstract] [Full Text]  
  • Flynn, B., Wang, V., Sacks, D. L., Seder, R. A, Verthelyi, D. (2005). Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/A Oligodeoxynucleotides Expressing CpG Motifs. Infect. Immun. 73: 4948-4954 [Abstract] [Full Text]  
  • Ito, S., Ishii, K. J., Ihata, A., Klinman, D. M. (2005). Contribution of Nitric Oxide to CpG-Mediated Protection against Listeria monocytogenes. Infect. Immun. 73: 3803-3805 [Abstract] [Full Text]  
  • Ito, S., Ishii, K. J., Gursel, M., Shirotra, H., Ihata, A., Klinman, D. M. (2005). CpG Oligodeoxynucleotides Enhance Neonatal Resistance to Listeria Infection. J. Immunol. 174: 777-782 [Abstract] [Full Text]  
  • Deng, J. C., Moore, T. A., Newstead, M. W., Zeng, X., Krieg, A. M., Standiford, T. J. (2004). CpG Oligodeoxynucleotides Stimulate Protective Innate Immunity against Pulmonary Klebsiella Infection. J. Immunol. 173: 5148-5155 [Abstract] [Full Text]  
  • Ito, S.-i., Ishii, K. J., Shirota, H., Klinman, D. M. (2004). CpG Oligodeoxynucleotides Improve the Survival of Pregnant and Fetal Mice following Listeria monocytogenes Infection. Infect. Immun. 72: 3543-3548 [Abstract] [Full Text]  
  • Branger, J., Leemans, J. C., Florquin, S., Weijer, S., Speelman, P., van der Poll, T. (2004). Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol 16: 509-516 [Abstract] [Full Text]  
  • Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., Rosenthal, K. L. (2003). Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2. J. Virol. 77: 8948-8956 [Abstract] [Full Text]  
  • FATTORINI, L., CRETI, R., NISINI, R., PIETROBONO, R., FAN, Y., STRINGARO, A., ARANCIA, G., SERLUPI-CRESCENZI, O., IONA, E., OREFICI, G. (2002). Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against Mycobacterium avium infection. J Med Microbiol 51: 1071-1079 [Abstract] [Full Text]  
  • Chackerian, A., Alt, J., Perera, V., Behar, S. M. (2002). Activation of NKT Cells Protects Mice from Tuberculosis. Infect. Immun. 70: 6302-6309 [Abstract] [Full Text]